Plunkett Research Online: Orexo

OREXO (ORXOY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Orexo AB is a specialty pharmaceutical company. The Company is engaged in developing products using its proprietary drug delivery technology. Its primary products are Abstral, Edluar, Diabact and Zubsolv......



Orexo
Ticker: ORXOY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 46 187808800
Fax: 46 187808888
Address: Virdings alle 32 A
P.O. Box 303
Uppsala, SE-75105 Sweden

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription

Orexo AB is a specialty pharmaceutical company. The Company is engaged in developing products using its proprietary drug delivery technology. Its primary products are Abstral, Edluar, Diabact and Zubsolv......See More See More

Auditor: Ernst & Young
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: